NEW YORK, July 26 (Xinhua) — COVAX, the global COVID-19 vaccine equity scheme, has agreed to buy 110 million Chinese doses of Sinovac and Sinopharm, thus gaining immediate access to lifesaving vaccines that are proved to be safe and effective, a vaccine expert has said.<\/p>\n\n\n\n
Such a decision by COVAX offers “some advantages in low-resource settings when most global manufacturers are unable to supply COVAX with the volumes it needs,” said Seth Berkley, chief executive of Gavi, or The Vaccine Alliance, a public-private global health partnership with the goal of increasing access to immunization in poor countries.<\/p>\n\n\n\n
“More than 50 percent of U.S. citizens have been fully vaccinated, but only 1 to 2 percent of people in lower-income countries have received their first dose,” said Berkley in an Opinion article published by The Washington Post on Sunday.<\/p>\n\n\n\n
“To stop the virus from circulating and continuing to mutate, we urgently need to address this vaccine divide,” said the expert. <\/p>\n\n\n\n
Source: http:\/\/www.xinhuanet.com\/english\/2021-07\/27\/c_1310089319.htm<\/p>","protected":false},"excerpt":{"rendered":"
NEW YORK, July 26 (Xinhua) — COVAX, the global COVID-19 vaccine equity scheme, has agreed to buy 110 million Chinese doses of Sinovac and Sinopharm, thus gaining immediate access to lifesaving vaccines that are proved to be safe and effective, a vaccine expert has said. Such a decision by COVAX […]<\/p>","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_themeisle_gutenberg_block_has_review":false,"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_newsletter_tier_id":0,"jetpack_publicize_message":"","jetpack_is_tweetstorm":false,"jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","enabled":false}}},"categories":[28],"tags":[],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":2449,"url":"https:\/\/www.govisachina.com\/zh\/2021\/08\/16\/contributions-to-covax-reflect-chinas-commitment-to-global-anti-covid-19-fight-bangladesh-health-experts\/","url_meta":{"origin":2417,"position":0},"title":"Contributions to COVAX reflect China’s commitment to global anti-COVID-19 fight: Bangladesh health experts","author":"Visa China","date":"8\u6708 16, 2021","format":false,"excerpt":"DHAKA, Aug. 12 (Xinhua) -- China's contributions through the COVAX Facility have reflected Beijing's commitment to global anti-COVID-19 fight, Bangladesh health experts said. They expressed appreciation of China's contributions after Bangladesh Tuesday night received 1.7 million Chinese COVID-19 vaccine doses shipped via the COVAX Facility. This is the first among\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":2190,"url":"https:\/\/www.govisachina.com\/zh\/2021\/05\/10\/who-approval-of-sinopharm-vaccine-set-to-benefit-world-coronavirus-fight\/","url_meta":{"origin":2417,"position":1},"title":"WHO approval of Sinopharm vaccine set to benefit world coronavirus fight","author":"Visa China","date":"5\u6708 10, 2021","format":false,"excerpt":"By BO LEUNG in London The World Health Organization's approval to give emergency use to the COVID-19 vaccine manufactured by China's Sinopharm has been welcomed by experts and health regulators worldwide. On Friday, the WHO gave the vaccine the green light, paving the way for potentially millions of doses to\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":2314,"url":"https:\/\/www.govisachina.com\/zh\/2021\/06\/02\/who-validates-chinas-sinovac-covid-19-vaccine-for-emergency-use\/","url_meta":{"origin":2417,"position":2},"title":"WHO validates China’s Sinovac COVID-19 vaccine for emergency use","author":"Visa China","date":"6\u6708 2, 2021","format":false,"excerpt":"GENEVA, June 1 (Xinhua) The World Health Organization (WHO) validated on Tuesday the CoronaVac COVID-19 vaccine developed by Chinese pharmaceutical company Sinovac for emergency use. \"I am happy to announce that the Sinovac coronavirus vaccine has been given WHO Emergency Use Listing (EUL) after being found to be safe, effective,\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":2401,"url":"https:\/\/www.govisachina.com\/zh\/2021\/07\/13\/providing-500-mln-vaccine-doses-to-world-china-aims-to-enhance-intl-cooperation-against-covid-19\/","url_meta":{"origin":2417,"position":3},"title":"Providing 500 mln vaccine doses to world, China aims to enhance int’l cooperation against COVID-19","author":"Visa China","date":"7\u6708 13, 2021","format":false,"excerpt":"BEIJING, July 13 (Xinhua) -- Chinese vaccines are gathering steam across the world, injecting strong impetus into the global fight against COVID-19 as deaths from the virus topped 4 million worldwide and variants spread to more than 100 countries. As a steadfast advocate for equitable vaccine distribution around the globe,\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":2441,"url":"https:\/\/www.govisachina.com\/zh\/2021\/08\/09\/china-takes-lead-at-intl-forum-addressing-covid-19-vaccine-inequality-media\/","url_meta":{"origin":2417,"position":4},"title":"China takes lead at int’l forum addressing COVID-19 vaccine inequality: media","author":"Visa China","date":"8\u6708 9, 2021","format":false,"excerpt":"HONG KONG, Aug. 9 (Xinhua) -- China is playing a leading role in addressing the widening gap in the distribution of COVID-19 vaccines between richer and poorer countries, said an opinion piece published in the South China Morning Post recently. China will strive to provide 2 billion COVID-19 vaccine doses\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":2439,"url":"https:\/\/www.govisachina.com\/zh\/2021\/08\/06\/xinhua-headlines-china-is-keeping-its-word-in-building-global-immunity-barrier\/","url_meta":{"origin":2417,"position":5},"title":"Xinhua Headlines: China is keeping its word in building global immunity barrier","author":"Visa China","date":"8\u6708 6, 2021","format":false,"excerpt":"BEIJING, Aug. 5 (Xinhua) -- China will strive to provide 2 billion COVID-19 vaccine doses to the world throughout this year and offer 100 million U.S. dollars to COVAX, Chinese President Xi Jinping said here Thursday, marking a further step by China in honoring its commitment to making vaccines a\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/posts\/2417"}],"collection":[{"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/comments?post=2417"}],"version-history":[{"count":1,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/posts\/2417\/revisions"}],"predecessor-version":[{"id":2418,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/posts\/2417\/revisions\/2418"}],"wp:attachment":[{"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/media?parent=2417"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/categories?post=2417"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/tags?post=2417"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}